In vitro dynamic degradation behavior of new magnesium alloy for orthopedic applications.

We report on methodologies for use in the design of a biodegradable Mg alloy appropriate for load-bearing but temporary orthopedic implant applications. Comparative studies of Mg-5Ca and Mg-5Ca-1Zn were conducted to explore the effects of a combination of minor alloying and hot extrusion, on the alloy's mechanical properties and corrosion resistance. The extruded Mg-5Ca-1Zn exhibited high ultimate compressive strength of 385 MPa and suffered no significant structural degradation even after immersion in simulated body fluid for 30 days.

Rapid in vitro corrosion induced by crack-like pathway in biodegradable Mg-10% Ca alloy.

The in vitro corrosion mechanism of the biodegradable cast Mg-10% Ca binary alloy in Hanks' solution was evaluated through transmission electron microscopy observations. The corrosion behavior depends strongly on the microstructural peculiarity of Mg₂Ca phase surrounding the island-like primary Mg phase and the fast corrosion induced by the interdiffusion of O and Ca via the Mg₂Ca phase of lamellar structure. At the corrosion front, we found that a nanosized crack-like pathway was formed along the interface between the Mg₂Ca phase and the primary Mg phase.

Biodegradability engineering of biodegradable Mg alloys: tailoring the electrochemical properties and microstructure of constituent phases.

Crystalline Mg-based alloys with a distinct reduction in hydrogen evolution were prepared through both electrochemical and microstructural engineering of the constituent phases. The addition of Zn to Mg-Ca alloy modified the corrosion potentials of two constituent phases (Mg + Mg2Ca), which prevented the formation of a galvanic circuit and achieved a comparable corrosion rate to high purity Mg. Furthermore, effective grain refinement induced by the extrusion allowed the achievement of much lower corrosion rate than high purity Mg.

Hexaaqua-zinc(II) bis-(2,4,5-tricarboxybenzoate) 4,5-diaza-fluoren-9-one disolvate dihydrate.

The asymmetric unit of the title complex, [Zn(H(2)O)(6)](C(10)H(5)O(8))(2)·2C(11)H(6)N(2)O·2H(2)O, contains one half of the complex cation with the Zn(II) ion located on an inversion center, a monovalent 2,4,5-tricarboxybenzoate (1,2,4,5-BTC) counter-anion, a 4,5-diaza-fluoren-9-one (DAFO) mol-ecule and an uncoordinated water mol-ecule. In the crystal structure, O-H⋯O and O-H⋯N hydrogen bonds link the cations, anions and water mol-ecules into a three-dimensional network.